treatment cessation using venetoclax-based therapy for older patients with aml
Published 3 years ago • 227 plays • Length 3:59Download video MP4
Download video MP3
Similar videos
-
5:31
the role of venetoclax in older patients with aml
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
1:12
hma in combination with venetoclax and magrolimab in the treatment of aml
-
1:59
the efficacy of venetoclax-based salvage therapy in patients with previously treated r/r aml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
1:18
venetoclax combination therapies in aml
-
1:11
treatment options for patients with cll after failure of covalent btk inhibitors and venetoclax
-
3:35
safety and efficacy of venetoclax-based regimens for aml
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:16
venetoclax-based salvage therapy in patients with r/r aml previously treated with targeted agents
-
2:16
rationale for 10-day decitabine with venetoclax for high-risk aml
-
2:21
infectious complications & outcomes of patients with aml receiving treatment with hmas ± venetoclax
-
5:12
an insight into myelomatch: enabling rapid advancements in the treatment of myeloid malignancies
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
1:19
new treatments for aml
-
4:20
updates from a study evaluating astx727 venetoclax for patients with aml
-
2:27
low-dose azacitidine and venetoclax as maintenance therapy in patients with aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml